About Mark Wainberg
Mark Arnold Wainberg, was a Canadian HIV/AIDS researcher and HIV/AIDS activist. He was the director of the McGill University AIDS Centre at the Montreal Jewish General Hospital and Professor of Medicine and of Microbiology at McGill University. His laboratory primarily studies HIV reverse transcriptase, the molecular basis for drug resistance, and gene therapy. He received a B.Sc. from McGill University in 1966, a Ph.D. from Columbia University in 1972, and did his post-doctoral research at Hadassah Medical School of the Hebrew University. Wainberg and his collaborators were the first to identify the antiviral capabilities of 3TC in 1989 and test the drug in patients. 3TC is also called lamivudine. Wainberg founded the Journal of the International AIDS Society in 2004, which he was still supporting as one of its three Editors-in-Chief. Mark Arnold Wainberg, (21 April 1945 – 11 April 2017) was a Canadian HIV/AIDS researcher and HIV/AIDS activist. On September 30, 2024 McGill University and the Montreal Jewish General Hospital established the Mark Wainberg Centre for Viral Diseases at McGill University in memory of the pioneering medical researcher.
Biography source: Wikipedia. The profile adds birthday-specific historical context from the Celebs Birthday Today editorial database.